Hearing evaluation of head and neck cancer patients (HNCP): Comparison of CTCAE, Brock and Chang adverse event (AE) criteria in patients receiving cisplatin (CDDP)

Por Colevas, A. D., Lira, R. R., Colevas, E. A., Lavori, P. W., Chan, C., Shultz, D. B., Chang, K. W.
Publicado no Head Neck (2014)